Showing results (41-50 of 74) with videos related to

Sort By:
Pageof 8
Anticancer Research|January 29, 2000
Expression patterns of the novel catenin p120cas in gastrointestinal cancersA J Karayiannakis, K N Syrigos, D Alexiou, et al.
European Journal of Cancer (Oxford, England : 1990)|November 27, 2001
Serum levels of E-selectin, ICAM-1 and VCAM-1 in colorectal cancer patients: correlations with clinicopathological features, patient survival and tumour surgeryD Alexiou, A J Karayiannakis, K N Syrigos, et al.
Journal of Thrombosis and Thrombolysis|December 2, 2019
Epidemiology and diagnosis of pulmonary embolism in lung cancer patients: is there a role for age adjusted D-dimers cutoff?I Anagnostopoulos, S Lagou, M K Spanorriga, et al.
Hybridoma|January 8, 2000
Prognostic significance of autoantibodies against tropomyosin in patients with colorectal adenocarcinomaK N Syrigos, A Charalampopoulos, K Pliarchopoulou, et al.
Hepato-Gastroenterology|May 6, 1999
E-cadherin expression correlates with tumor differentiation in colorectal cancerG Karatzas, A J Karayiannakis, K N Syrigos, et al.
Annals of Surgical Oncology|June 8, 2002
Colonoscopy in asymptomatic individuals with a family history of colorectal cancerK N Syrigos, A Charalampopoulos, J L Ho, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 1, 1997
Cancer-related thromboembolic disease in patients with solid tumours: a retrospective analysisK J Harrington, A R Bateman, K N Syrigos, et al.
Pathology Oncology Research : POR|May 22, 2008
Right sited renal cell carcinoma metastasizing to the contralateral ovary: case report and review of the literatureV K Anagnostou, D G Tiniakos, M Chorti, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1997
Thyroid autoantibodies and thyroid function in patients with pancreatic adenocarcinomaI Fyssas, K N Syrigos, M M Konstantoulakis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 29, 2000
Pegylated liposomes have potential as vehicles for intratumoral and subcutaneous drug deliveryK J Harrington, G Rowlinson-Busza, K N Syrigos, et al.
Pageof 8